VMBIP Newsletter – May 30, 2008
Please scroll past the charts for VMBIP updates.
McKesson Performance Dashboard 
CDC Weekly Performance Metric Scorecard

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 5-9-08: 80.6 percent
Week Ending 5-16-08: 65.5 percent
Week Ending 5-23-08:  74.1 percent.  The residual effect of the duplicate orders continued to plague distribution this week.  Much progress has been made and all indications are that we return to green in the next two weeks.
Weighted Average Last 3 Weeks: 74.8 percent
Explanation:  5-16:  On May 5 a duplicate order was received and the entire order file delivered to McKesson was not loaded into SAP.  The duplicate was resolved, a corrected file was sent to McKesson, and the data was loaded into SAP on 5-7.  However, the CDC process dates (McKesson process start dates) for the delayed file still reflect 5-5.  When the 5-5 orders are removed, the metrics are 73.8 percent (3 day) and 99.8 (5 day).

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending 5-9-08: 100 percent
Week Ending 5-16-08: 97.8 percent
Week Ending 5-23-08:  89.7 percent
Weighted Average Last 3 Weeks:   96 percent
Explanation:  none

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending 5-9-08:  99.99 percent
Week Ending 5-16-08:  99.94 percent
Week Ending 5-23-08:  99.88 percent
Weighted Average Last 3 Weeks:  99.94 percent
Explanation:  none

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending 5-9-08:  99.99 percent
Week Ending 5-16-08:  99.14 percent
Week Ending 5-23-08:  99.11 percent 
Weighted Average Last 3 Weeks:  99.42 percent
Explanation:  none

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending 5-9-08:  99.99 percent
Week Ending 5-16-08:  99.95 percent
Week Ending 5-23-08:  99.90  percent
Weighted Average Last 3 Weeks:  99.95 percent  
Explanation:  none

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending 5-9-08:  100 percent
Week Ending 5-16-08:  99 percent
Week Ending 5-23-08:  100 percent
Weighted Average Last 3 Weeks: 100 percent  
Explanation:  None

F
Metric: State Funded PO Transmission
Week Ending 5-9-08:  100 percent
Week Ending 5-16-08:  100 percent
Week Ending 5-23-08:  100 percent
Weighted Average Last 3 Weeks: 100 percent  
Explanation:  5-16:  Received short dated product and had to wait on approval form CDC to receive into inventory.

A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder  - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		 
B.    percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder	
C1.   percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable or customer not available, or carrier damage
C2.    percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address and delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 
D.    percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	
E.    percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and transmits to CDC within 24 (flu) and 48 (other) hrs of delivery by manufacturer
F.    percent of grantee replenishment orders McKesson faxes and e-mails receipt of to grantees within 48 hrs of delivery by manufacturer

Short-dated vaccine and CDC chose to wait until full shelf-life was available before reordering. Inventory was received mid week; Hep AB (900 doses).  A large order was placed with low inventory before a replenishment order arrived.  Vaccine en route. Hep B – Adult (1000 doses).  A large order was placed with low inventory before a replenishment order arrived.  Vaccine en route. Vaccines on Allocation DTAP-HIB, HEPB-HIB, HIB (TriHIBit, PedvaxHIB and ActHIB) and FLU. Vaccines placed on backorder during the most recent week: DTAP-HIB (885 doses) – low inventory at Memphis was depleted.  Inventory was received mid week ; TD (3650 doses) – Manufacturer was shipping 

McKesson Performance Dashboard – Shipping Metrics by Distribution Center
CDC Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 5-9-08: 87.0 percent
Week Ending 5-16-08: 58.1 percent
Week Ending 5-23-08:  75.4 percent
Weighted Average Last 3 Weeks:  73.3 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending 5-9-08: 100 percent
Week Ending 5-16-08: 96.7 percent
Week Ending 5-23-08:  86.2 percent
Weighted Average Last 3 Weeks:  94.4 percent
Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 5-9-08:  83.2 percent
Week Ending 5-16-08: 80.6 percent
Week Ending 5-23-08:  70 percent
Weighted Average Last 3 Weeks:  78.5 percent 
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending 5-9-08: 100 percent
Week Ending 5-16-08:  99.9 percent
Week Ending 5-23-08:  100 percent
Weighted Average Last 3 Weeks: 100 percent
Explanation:  none
 
A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder – an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order
B.   percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder

VMBIP Updates

•	Special thanks go to everyone who attended Vaccine University. Your participation and feedback were integral in making the conference a success.

•	POB project officers will be following up with Memphis-serviced grantees next week to push out some vaccines that will expire within the next 5 months.
•	During the Vaccine University centralized distribution plenary session, McKesson announced a change to its organizational structure.  McKesson has established two account manager positions to develop deeper relationships with grantees and POB project officers and increase response time and customer satisfaction.  Jennifer Boss is the account manager for the western region and Scott Silvers is the account manager for the eastern region.  Please refer to the map below to identify your account manager.  The roles of the account managers are as follows: coordination of service support and service communications; coordination of calls with PPOCs, grantees and McKesson operations; ongoing; participation in face-to-face meetings with grantees; ongoing communication with customer care manager, team lead, McKesson management team, POB project officers, and assigned grantees; support of CDC projects and McKesson operations through procedural and systematic business developments; preparation and delivery of key monthly/quarterly business reviews; and proactive management of grantee issues. 
Account Manager Coverage
Jennifer Boss
Jennifer.Boxx@McKesson.com
Account Manager West

Scott Silvers
Scott.Silvers@McKesson.com
Account Manager East

As a reminder, VMBIP related all grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov  or Julie Orta
jio7@cdc.gov, with a cc to your project officer. 

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/vmbip-nl-05-30-08.rtf